Novartis Looks To New Models For Neglected Disease Research

SINGAPORE - Novartis Head of Corporate Research Paul Herrling is touting a new model for developing drugs for infectious diseases and is presenting his ideas April 3 to a U.S. Institute of Medicine Working Group, which is advising President Barack Obama on neglected diseases